文献速递前列腺癌

血糖生成指数对异种移植小鼠模型前列腺癌进展的影响

The effects of glycemic index on prostate cancer progression in a xenograft mouse model.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2023-12-11

研究在注射LAPC-4细胞的雄性SCID小鼠中比较低血糖生成指数(LoGI)与高血糖生成指数(HiGI)西式饮食对前列腺癌生长的影响,两组肿瘤体积、增殖和总生存均无显著差异,LoGI组体脂降低30%但代谢指标差异未达统计学显著。

要点

  • 低血糖生成指数饮食未延缓小鼠前列腺癌生长或改善生存。
  • LoGI组随机化后35天体脂较HiGI组低30%(P=0.007),体重相似。
  • 仅改善碳水化合物质量而维持高碳水摄入可能不足以减缓前列腺癌生长。

核心结论

  • 在该单一小鼠异种移植模型中,与高血糖生成指数饮食相比,低血糖生成指数饮食未延缓前列腺癌生长或生存,尽管有胰岛素/IGF-1通路激活降低的提示。
  • 作者认为,仅改善碳水化合物质量而维持高碳水化合物饮食可能不能有效减缓前列腺癌生长。

研究设计与样本

  • 雄性SCID小鼠注射LAPC-4细胞,单笼饲养,肿瘤平均达200 mm3时随机分为LoGI组(48%碳水化合物千卡,来自Hylon-VII)或HiGI西式饮食组(48%碳水化合物千卡,来自蔗糖)。
  • 每周测量体重和肿瘤体积,随机化后35天评估体成分,研究终点肿瘤体积达800 mm3时测血糖、血清胰岛素、IGF-1和IGFBP3。
  • 对小鼠肿瘤行RNA测序分析基因表达,人肿瘤使用前列腺癌转录组图谱分析。

主要发现

  • 两组肿瘤体积(P > 0.05)、肿瘤增殖(P = 0.29)和总生存(P = 0.15)无显著差异。
  • 随机化后35天,LoGI组体脂较HiGI组低30%(P = 0.007),体重相似(P = 0.58)。
  • 处死时LoGI组小鼠肝脏较HiGI组小(P < 0.001),血糖(P = 0.15)、胰岛素(P = 0.11)、IGF-1(P = 0.07)和IGF-1:IGFBP3比值(P = 0.05)较低,IGFBP3较高(P = 0.09),但这些代谢差异均未达统计学显著。
  • 小鼠肿瘤中观察到饮食相关的差异基因表达和通路富集,LoGI组上调和下调最显著的基因表达模式更接近人良性前列腺组织而非前列腺癌。

局限性

  • 原文自述为单一小鼠异种移植模型(single mouse xenograft model)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previously, we found low-carbohydrate diets slowed prostate cancer (PC) growth and increased survival vs. a Western diet in mice, by inhibiting the insulin/IGF-1 axis. Thus, we tested whether modifying carbohydrate quality to lower glycemic index (GI) without changing quantity results in similar benefits as with reduced quantity. METHODS: Male SCID mice injected with LAPC-4 cells were single-housed and randomized when their tumors reached 200 mm3 on average to a LoGI (48% carbohydrate kcal, from Hylon-VII) or HiGI Western diet (48% carbohydrate kcal, from sucrose). Body weight and tumor volume were measured weekly. Body composition was assessed 35 days after randomization. Blood glucose and serum insulin, IGF-1 and IGFBP3 were measured at study end when tumor volumes reached 800 mm3. We analyzed gene expression of mice tumors by RNA-sequencing and human tumors using the Prostate Cancer Transcriptome Atlas. RESULTS: There were no significant differences in tumor volume (P > 0.05), tumor proliferation (P = 0.29), and overall survival (P = 0.15) between groups. At 35 days after randomization, the LoGI group had 30% lower body fat (P = 0.007) despite similar body weight (P = 0.58). At sacrifice, LoGI mice had smaller livers (P < 0.001) and lower glucose (P = 0.15), insulin (P = 0.11), IGF-1 (P = 0.07) and IGF-1:IGFBP3 ratio (P = 0.05), and higher IGFBP3 (P = 0.09) vs. HiGI, although none of these metabolic differences reached statistical significance. We observed differential gene expression and pathway enrichment in mice tumors by diet. The most upregulated and downregulated gene in the LoGI group showed expression patterns more closely resembling expression in human benign prostate tissue vs. PC. CONCLUSIONS: In this single mouse xenograft model, consuming a low GI diet did not delay PC growth or survival vs. a high GI diet despite suggestions of decreased activation of the insulin/IGF-1 pathway. These data suggest that improving carbohydrate quality alone while consuming a high carbohydrate diet may not effectively slow PC growth.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Galván GC, Macias E, Sanders S, et al. The effects of glycemic index on prostate cancer progression in a xenograft mouse model. Prostate Cancer Prostatic Dis. 2023. PMID: 38082056. doi:10.1038/s41391-023-00769-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。